ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1550

Comorbidities of Rheumatoid Arthritis: Results from the Korean National Health and Nutrition Examination Survey

Hyemin Jeong1, Young Hee Eun2, Eun-Jung Park3, Hyungjin Kim4, Ji Young Chae5, Jaejoon Lee1, Hoon-Suk Cha2 and Eun-Mi Koh4, 1Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Department of Medicine, Division of Rheumatology, Department of Medicine, Jeju National University Hospital, Jeju University School of Medicine, Jeju, South Korea, 4Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 5Departement of Internal Medicine, Bundang Jesaeng General Hospital, Seongnam, Korea, The Republic of

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Co-morbidities and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   To evaluate the prevalence of comorbidities in patients with rheumatoid arthritis (RA) compared with non-RA population.

Methods:   The 2010-2012 Korea National Health and Nutrition Examination Survey (KNHANES), which assesses the general health status of populations in South Korea using interviews and basic health assessment, was analyzed retrospectively. Weighted prevalence and odds ratio (OR) of comorbidities were analyzed in patients with RA compared with non-RA population.

Results:   The overall weighted (n = 37,453,158) prevalence RA was 1.5%. Patients with RA were older and more female predominant than subjects without RA. The prevalence of living in urban area, collage graduation, drinking and smoking was lower in patients with RA than non-RA. Patients with RA had more comorbidities including hypertension, dyslipidemia, myocardial infarction (MI) or angina, stoke, osteoarthritis, lung cancer, colon cancer, pulmonary tuberculosis, asthma, diabetes, depression, thyroid disease and chronic kidney disease. After adjusting socioeconomic and lifestyle characteristics, RA was associated with the increased the prevalence of MI or angina (OR 1.86, 95% CI 1.17-2.96, p = 0.009), pulmonary Tb (OR 1.95, 95% CI 1.24 to 3.09, p = 0.004), asthma (OR 1.97, 95% CI 1.05 to 3.71, p = 0.036), thyroid disease (OR 1.71, 95% CI 1.05 to 2.77), depression (OR 2.38, 95% CI 1.47 to 3.85, p < 0.001) and hepatitis B (OR 2.34, 95% CI 1.15 to 4.80, p = 0.020) compared with non-RA population. Prevalence of solid cancer was not significantly associated with RA after adjustment.

Conclusion:   RA was associated with increased risk of cardiovascular disease, pulmonary Tb, asthma, thyroid disease, depression and hepatitis B.


Disclosure: H. Jeong, None; Y. H. Eun, None; E. J. Park, None; H. Kim, None; J. Y. Chae, None; J. Lee, None; H. S. Cha, None; E. M. Koh, None.

To cite this abstract in AMA style:

Jeong H, Eun YH, Park EJ, Kim H, Chae JY, Lee J, Cha HS, Koh EM. Comorbidities of Rheumatoid Arthritis: Results from the Korean National Health and Nutrition Examination Survey [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/comorbidities-of-rheumatoid-arthritis-results-from-the-korean-national-health-and-nutrition-examination-survey/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comorbidities-of-rheumatoid-arthritis-results-from-the-korean-national-health-and-nutrition-examination-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology